Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 8/20 | 0.43 |
| ▸ | ADORA2B | P29275 | 8/20 | 0.43 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.43 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.34 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.34 |
| ▸ | JAK2 | O60674 | 1/20 | 0.34 |
| ▸ | JAK3 | P52333 | 1/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.34 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.34 |
| ▸ | IDH1 | O75874 | 1/20 | 0.33 |
| ▸ | CTSS | P25774 | 1/20 | 0.33 |
| ▸ | CTSK | P43235 | 1/20 | 0.33 |
| ▸ | PTGDR | Q13258 | 1/20 | 0.33 |
| ▸ | CDC7 | O00311 | 1/20 | 0.33 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.33 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.33 |
| ▸ | PAK4 | O96013 | 1/20 | 0.33 |
| ▸ | CDK2 | P24941 | 1/20 | 0.33 |
| ▸ | FLT3 | P36888 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20436646 | 1.00 | ADORA2A (0.43) | ADORA2AADORA2BADORA1CYP19A1ALOX12 | |
| SCHEMBL20436666 | 0.91 | ADORA2A (0.46) | ADORA2AADORA2BADORA1CYP19A1HDAC2 | |
| SCHEMBL30402160 | 0.90 | ADORA2B (0.41) | ADORA2AADORA2BADORA1CYP19A1HDAC2 | |
| SCHEMBL20400848 | 0.90 | ADORA2B (0.41) | ADORA2AADORA2BADORA1CYP19A1HDAC2 | |
| SCHEMBL20416836 | 0.90 | ADORA2B (0.41) | ADORA2AADORA2BADORA1CYP19A1HDAC2 | |
| SCHEMBL20400846 | 0.90 | ADORA2B (0.41) | ADORA2AADORA2BADORA1CYP19A1HDAC2 | |
| SCHEMBL20436645 | 0.88 | ADORA2A (0.44) | ADORA2AADORA2BADORA1CYP19A1ALOX12 | |
| SCHEMBL20416662 | 0.87 | ADORA2A (0.45) | ADORA2AADORA2BADORA1CYP19A1JAK3 | |
| SCHEMBL20421937 | 0.87 | ADORA2A (0.45) | ADORA2AADORA2BADORA1CYP19A1JAK3 | |
| SCHEMBL30401383 | 0.87 | ADORA2A (0.45) | ADORA2AADORA2BADORA1CYP19A1JAK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180215730-A1 | AZOLOPYRIMIDINE FOR THE TREATMENT OF CANCER-RELATED DISORDERS | ARCUS BIOSCIENCES, INC. | 2018-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180215730-A1 | AZOLOPYRIMIDINE FOR THE TREATMENT OF CANCER-RELATED DISORDERS | ADORA2A, ADORA2B, ADORA1 | ADORA2A 1/4885ADORA2B 2/4885ADORA1 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.